Axcan Offers to Acquire Eurand to Accelerate its Speciality Pharma Business
By Heather Cartwright
Pharma Deals Review: Vol 2010 Issue 10 (Table of Contents)
Published: 17 Dec-2010
DOI: 10.3833/pdr.v2010.i10.1412 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
The Independent Directors of the speciality pharmaceutical company Eurand, acting on behalf of the company’s Board, have approved an acquisition agreement under which Axcan Holdings will buy Eurand for US$12...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS